Een domein Antilichamen

Datum:
Locatie: Gent, Belgium
Toevoegen aan persoonlijke kalender

Full-length antibodies have captured a significant fraction of the biopharmaceuticals market but are not without their limitations. Antibody fragments provide the opportunity for new therapeutic and diagnostic possibilities by combining beneficial features of full-length antibodies with some of the advantages of small molecules.